{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T01:25:31Z","timestamp":1769909131102,"version":"3.49.0"},"reference-count":53,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) is a well-known cause of squamous cell carcinomas of anogenital and oropharyngeal regions, where treatment strategies and prognosis depend on HPV status. The significance of HPV status in tumors arising along the urinary tract is not well established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To provide detailed clinical, morphologic, immunohistochemical, and molecular analysis of HPV+ urinary tract carcinomas (UTCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>We identified and retrospectively examined 12 HPV+ UTCs, confirmed by high-risk HPV in situ hybridization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>The HPV+ UTCs originated from the urethra (9) and urinary bladder (3); 5 of 12 (42%) presented with nodal metastasis. On morphology, HPV+ UTCs were predominantly basaloid; well-differentiated squamous areas were focally seen. Available immunohistochemistry (IHC) showed strong staining for p16 (11 of 11), p63 (12 of 12), cytokeratin (CK) 903 (11 of 11), and CK5\/6 (11 of 11); variable staining for GATA3 (8 of 12) and CK7 (4 of 11); and rare uroplakin II staining (1 of 12). Molecular analysis revealed the most frequently altered genes: KMT2C (42%), PIK3CA (42%), and KMT2D (25%). In contrast to published conventional urothelial and squamous cell carcinoma molecular data, TERTp mutation was rare (8%), and no TP53 or CDKN2A aberrations were identified. During available follow-up (11 of 12; median, 39 months), 6 patients required treatment for recurrence; ultimately, 1 died of disease, 2 were alive with disease, and 8 had no evidence of disease. Finally, we provide 11 HPV\u2212 squamous predominant UTCs for IHC and molecular comparisons; notably, a subset of HPV\u2212 UTCs was positive for p16 IHC (27%), making p16 IHC a less-specific surrogate marker for HPV status at this site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>HPV+ UTCs show distinct clinical, morphologic, and molecular characteristics, suggesting important roles for HPV in UTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2023-0285-oa","type":"journal-article","created":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T20:01:15Z","timestamp":1711915275000},"page":"30-38","source":"Crossref","is-referenced-by-count":2,"title":["Clinicopathologic and Molecular Characterization of High-Risk Human Papillomavirus\u2013Positive Carcinomas of the Urinary Tract"],"prefix":"10.5858","volume":"149","author":[{"given":"Neslihan","family":"Kayraklioglu","sequence":"first","affiliation":[{"name":"From the Department of Pathology, University of California San Francisco (UCSF), San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley A.","family":"Stohr","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of California San Francisco (UCSF), San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Chan","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of California San Francisco (UCSF), San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"key":"2024122523514488900_i1543-2165-149-1-30-b01","doi-asserted-by":"crossref","first-page":"552028","DOI":"10.3389\/fpubh.2020.552028","article-title":"Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation","volume":"8","author":"Kombe Kombe","year":"2020","journal-title":"Front Public Health"},{"issue":"11","key":"2024122523514488900_i1543-2165-149-1-30-b02","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"2024122523514488900_i1543-2165-149-1-30-b03","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease","volume":"47","author":"Serrano","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"10","key":"2024122523514488900_i1543-2165-149-1-30-b04","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1158\/1055-9965.EPI-19-0038","article-title":"Incidence and demographic burden of HPV-associated oropharyngeal head and neck cancers in the United States","volume":"28","author":"Mahal","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"suppl 5","key":"2024122523514488900_i1543-2165-149-1-30-b05","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"2024122523514488900_i1543-2165-149-1-30-b06","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrc.2018.13","article-title":"Opportunities and challenges for human papillomavirus vaccination in cancer","volume":"18","author":"Roden","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2024122523514488900_i1543-2165-149-1-30-b07","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"2024122523514488900_i1543-2165-149-1-30-b08","doi-asserted-by":"crossref","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","article-title":"Biological and clinical aspects of HPV-related cancers","volume":"17","author":"Szymonowicz","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"2","key":"2024122523514488900_i1543-2165-149-1-30-b09","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.605","article-title":"Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins","volume":"19","author":"Yugawa","year":"2009","journal-title":"Rev Med Virol"},{"issue":"8","key":"2024122523514488900_i1543-2165-149-1-30-b10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"2024122523514488900_i1543-2165-149-1-30-b11","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1002\/j.1460-2075.1989.tb08594.x","article-title":"Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product","volume":"8","author":"Munger","year":"1989","journal-title":"EMBO J"},{"issue":"8","key":"2024122523514488900_i1543-2165-149-1-30-b12","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/PAS.0000000000000650","article-title":"Histologic typing in oropharyngeal squamous cell carcinoma: a 4-year prospective practice study with p16 and high-risk HPV mRNA testing correlation","volume":"40","author":"Gondim","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2024122523514488900_i1543-2165-149-1-30-b13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/B978-1-4160-5766-6.00022-4","volume-title":"Diagnostic Immunohistochemistry","author":"Rabban","year":"2010","edition":"3rd ed"},{"key":"2024122523514488900_i1543-2165-149-1-30-b14","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14518.1","article-title":"Recent advances in the management of anal cancer","volume":"7","author":"Symer","year":"2018","journal-title":"F1000Res"},{"key":"2024122523514488900_i1543-2165-149-1-30-b15","doi-asserted-by":"crossref","first-page":"105620","DOI":"10.1016\/j.oraloncology.2021.105620","article-title":"De-escalation studies in HPV-positive oropharyngeal cancer: how should we proceed","volume":"123","author":"Golusinski","year":"2021","journal-title":"Oral Oncol"},{"issue":"8","key":"2024122523514488900_i1543-2165-149-1-30-b16","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/2159-8290.CD-20-1760","article-title":"Tumor immunity and immunotherapy for HPV-related cancers","volume":"11","author":"Shamseddine","year":"2021","journal-title":"Cancer Discov"},{"issue":"29","key":"2024122523514488900_i1543-2165-149-1-30-b17","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II trial of de-intensified chemoradiotherapy for human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"37","author":"Chera","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"2024122523514488900_i1543-2165-149-1-30-b18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40463-018-0302-y","article-title":"The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review","volume":"47","author":"Liu","year":"2018","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"9","key":"2024122523514488900_i1543-2165-149-1-30-b19","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1158\/1078-0432.CCR-14-1101","article-title":"Genomic landscape of human papillomavirus-associated cancers","volume":"21","author":"Rusan","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"7536","key":"2024122523514488900_i1543-2165-149-1-30-b20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Cancer Genome Atlas Network","year":"2015","journal-title":"Nature"},{"issue":"10","key":"2024122523514488900_i1543-2165-149-1-30-b21","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/cncr.25777","article-title":"Etiologic role of human papillomavirus infection in bladder carcinoma","volume":"117","author":"Shigehara","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"2024122523514488900_i1543-2165-149-1-30-b22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/apm.13016","article-title":"Human papillomavirus and urinary bladder cancer revisited","volume":"128","author":"Jorgensen","year":"2020","journal-title":"APMIS"},{"issue":"3","key":"2024122523514488900_i1543-2165-149-1-30-b23","doi-asserted-by":"crossref","first-page":"e93525","DOI":"10.1371\/journal.pone.0093525","article-title":"Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cancer with squamous differentiation","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2024122523514488900_i1543-2165-149-1-30-b24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000474501","article-title":"Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomas","volume":"31","author":"Lu","year":"1997","journal-title":"Eur Urol"},{"issue":"1","key":"2024122523514488900_i1543-2165-149-1-30-b25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13027-022-00415-5","article-title":"Bladder cancer and human papillomavirus association: a systematic review and meta-analysis","volume":"17","author":"Khatami","year":"2022","journal-title":"Infect Agent Cancer"},{"issue":"3","key":"2024122523514488900_i1543-2165-149-1-30-b26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"issue":"11","key":"2024122523514488900_i1543-2165-149-1-30-b27","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/modpathol.2012.112","article-title":"Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection","volume":"25","author":"Blochin","year":"2012","journal-title":"Mod Pathol"},{"key":"2024122523514488900_i1543-2165-149-1-30-b28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.humpath.2017.08.006","article-title":"Carcinoma of the urethra","volume":"72","author":"Zhang","year":"2018","journal-title":"Hum Pathol"},{"issue":"11","key":"2024122523514488900_i1543-2165-149-1-30-b29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0046-8177(86)80422-1","article-title":"Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases","volume":"17","author":"Wain","year":"1986","journal-title":"Hum Pathol"},{"issue":"6","key":"2024122523514488900_i1543-2165-149-1-30-b30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0002-9440(10)65689-1","article-title":"Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions","volume":"153","author":"Sano","year":"1998","journal-title":"Am J Pathol"},{"issue":"2","key":"2024122523514488900_i1543-2165-149-1-30-b31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/his.13225","article-title":"p53 immunohistochemistry in high-grade urothelial carcinoma of the bladder is prognostically significant","volume":"71","author":"Hodgson","year":"2017","journal-title":"Histopathology"},{"issue":"9","key":"2024122523514488900_i1543-2165-149-1-30-b32","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/s41379-020-0543-y","article-title":"Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer","volume":"33","author":"Chan","year":"2020","journal-title":"Mod Pathol"},{"issue":"1","key":"2024122523514488900_i1543-2165-149-1-30-b33","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1038\/s41467-022-34251-3","article-title":"FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation","volume":"13","author":"Warrick","year":"2022","journal-title":"Nature Commun"},{"issue":"3","key":"2024122523514488900_i1543-2165-149-1-30-b34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cjp2.261","article-title":"Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling","volume":"8","author":"Hurst","year":"2022","journal-title":"J Pathol Clin Res"},{"issue":"5","key":"2024122523514488900_i1543-2165-149-1-30-b35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/00016489.2017.1405279","article-title":"Presenting symptoms and clinical findings in HPV-positive and HPV-negative oropharyngeal cancer patients","volume":"138","author":"Carpen","year":"2018","journal-title":"Acta Otolaryngol"},{"key":"2024122523514488900_i1543-2165-149-1-30-b36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.humpath.2019.09.013","article-title":"Morphology, p16, HPV, and outcomes in squamous cell carcinoma of the penis: a multi-institutional study","volume":"96","author":"Eich","year":"2020","journal-title":"Hum Pathol"},{"issue":"9","key":"2024122523514488900_i1543-2165-149-1-30-b37","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.93.9.4350","article-title":"Inhibition of cyclin D-CDK4\/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity","volume":"93","author":"Khleif","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2024122523514488900_i1543-2165-149-1-30-b38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12885-019-5536-1","article-title":"Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas","volume":"19","author":"Gao","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"2024122523514488900_i1543-2165-149-1-30-b39","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/s41598-018-37871-2","article-title":"Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology","volume":"9","author":"Nkili-Meyong","year":"2019","journal-title":"Sci Rep"},{"issue":"4951","key":"2024122523514488900_i1543-2165-149-1-30-b40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.2157286","article-title":"Association of human papillomavirus types 16 and 18 E6 proteins with p53","volume":"248","author":"Werness","year":"1990","journal-title":"Science"},{"issue":"4","key":"2024122523514488900_i1543-2165-149-1-30-b41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00432-021-03514-9","article-title":"TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features","volume":"147","author":"Kim","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"2024122523514488900_i1543-2165-149-1-30-b42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/jamaoncol.2016.1790","article-title":"The molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platform","volume":"3","author":"Morris","year":"2017","journal-title":"JAMA Oncol"},{"issue":"21","key":"2024122523514488900_i1543-2165-149-1-30-b43","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.3390\/cancers14215257","article-title":"The molecular interplay between human oncoviruses and telomerase in cancer development","volume":"14","author":"Tornesello","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"19","key":"2024122523514488900_i1543-2165-149-1-30-b44","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.3390\/cancers14194623","article-title":"The drivers, mechanisms, and consequences of genome instability in HPV-driven cancers","volume":"14","author":"Porter","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"18","key":"2024122523514488900_i1543-2165-149-1-30-b45","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1128\/JVI.77.18.9852-9861.2003","article-title":"Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression","volume":"77","author":"McMurray","year":"2003","journal-title":"J Virol"},{"issue":"24","key":"2024122523514488900_i1543-2165-149-1-30-b46","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1038\/sj.onc.1206528","article-title":"Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers","volume":"22","author":"Ferber","year":"2003","journal-title":"Oncogene"},{"key":"2024122523514488900_i1543-2165-149-1-30-b47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2021.01.028","article-title":"Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma","volume":"157","author":"Bauwens","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"2024122523514488900_i1543-2165-149-1-30-b48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJMe1003607","article-title":"Prognostic implications of HPV in oropharyngeal cancer","volume":"363","author":"Lowy","year":"2010","journal-title":"N Engl J Med"},{"key":"2024122523514488900_i1543-2165-149-1-30-b49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13027-020-00318-3","article-title":"Association of human papilloma virus (HPV) infection with oncological outcomes in urothelial bladder cancer","volume":"15","author":"Ohadian Moghadam","year":"2020","journal-title":"Infect Agent Cancer"},{"issue":"1-2","key":"2024122523514488900_i1543-2165-149-1-30-b50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000500467","article-title":"Is there any association between urothelial carcinoma of the bladder and human papillomavirus: a case-control study","volume":"104","author":"Sarier","year":"2020","journal-title":"Urol Int"},{"issue":"2","key":"2024122523514488900_i1543-2165-149-1-30-b51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3892\/or.2010.1083","article-title":"Human papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study","volume":"25","author":"Cai","year":"2011","journal-title":"Oncol Rep"},{"issue":"16","key":"2024122523514488900_i1543-2165-149-1-30-b52","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1002\/cam4.4091","article-title":"Detection of HPV infection in urothelial carcinoma using RNAscope: clinicopathological characterization","volume":"10","author":"Musangile","year":"2021","journal-title":"Cancer Med"},{"issue":"5","key":"2024122523514488900_i1543-2165-149-1-30-b53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/modpathol.2016.53","article-title":"High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder","volume":"29","author":"Cowan","year":"2016","journal-title":"Mod Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/1\/30\/3467496\/i1543-2165-149-1-30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/1\/30\/3467496\/i1543-2165-149-1-30.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:33Z","timestamp":1764790833000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/1\/article-p30.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4,1]]},"published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2023-0285-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}